Related Experiment Video
Updated: Jul 10, 2026

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
Urinary epidermal and insulin-like growth factor excretion in autistic children
B Anlar1, F Oktem, B Bakkaloglu
1Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey. banlar@hacettepe.edu.tr
Insights
Young autistic children show lower urinary insulin-like growth factor-1 (IGF-1) levels, suggesting altered IGF-1 metabolism. Further research is needed to understand this association in autism pathogenesis.
Area of Science:
- Biochemistry
- Developmental Biology
- Pediatric Neurology
Background:
- Growth factors play a role in the development and pathogenesis of autism spectrum disorder (ASD).
- Previous research suggests potential links between growth factor dysregulation and autism.
- Understanding these biological pathways is crucial for identifying potential biomarkers and therapeutic targets.
Purpose of the Study:
- To investigate the urinary excretion levels of key growth factors in young children diagnosed with autism.
- To compare these levels between autistic children and age-matched neurotypical controls.
- To explore the potential role of insulin-like growth factor-1 (IGF-1) in autism.
Main Methods:
- A cross-sectional study involving 34 autistic children (ages 2-5 years) and 29 age-matched controls.
- Measurement of daily urinary excretion of insulin-like growth factor-1 (IGF-1), epidermal growth factor, and IGF binding protein-3.
- Statistical analysis to compare urinary growth factor levels between the autism and control groups.
Main Results:
- Mean urinary IGF-1 levels were significantly lower in the group of autistic children compared to the control group (p=0.03).
- No significant differences were observed in height between the groups, indicating normal physical development.
- Urinary levels of epidermal growth factor and IGF binding protein-3 were also assessed, though specific findings are not detailed in the abstract.
Conclusions:
- The findings suggest a potential alteration in IGF-1 metabolism in young children with autism.
- Lower urinary IGF-1 may represent a biomarker for altered growth factor pathways in early autism.
- Longitudinal studies and provocation tests are recommended to establish causality and further elucidate the role of IGF-1 in autism.
Abstract:
Growth factors have been implicated in the pathogenesis of autism. We have investigated daily urinary excretion of insulin-like growth factor-1 (IGF-1), epidermal growth factor, and insulin-like growth factor binding protein-3 in autistic children (n=34, age 2-5 years) and age-matched control children (n=29). The mean urinary IGF-1 level was lower in the autism group than the control group (p=0.03). Height was normal. These findings suggest altered IGF-1 metabolism in young autistic children. The cause-effect relationship should be examined by longitudinal studies and insulin-like growth factor provocation tests.
Related Concept Videos
Diabetes Insipidus II: Pathophysiology
Diabetes Insipidus I: Introduction
Insulin Secretory Vesicles
Urine Studies I: Urinalysis
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
